Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001950467 | SCV002218749 | uncertain significance | Hajdu-Cheney syndrome | 2023-08-29 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1440665). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NOTCH2 protein function. This variant has not been reported in the literature in individuals affected with NOTCH2-related conditions. This variant is present in population databases (rs780904023, gnomAD 0.01%). This sequence change replaces histidine, which is basic and polar, with proline, which is neutral and non-polar, at codon 2293 of the NOTCH2 protein (p.His2293Pro). |
Fulgent Genetics, |
RCV002497818 | SCV002806771 | uncertain significance | Alagille syndrome due to a NOTCH2 point mutation; Hajdu-Cheney syndrome | 2021-12-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003913463 | SCV004735387 | uncertain significance | NOTCH2-related disorder | 2024-02-19 | criteria provided, single submitter | clinical testing | The NOTCH2 c.6878A>C variant is predicted to result in the amino acid substitution p.His2293Pro. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.014% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |